MYD88 and ovarian carcinoma: One study was carried out using a cell population CD44+MyD88+ enriched in epithelial ovarian cancer stem cells: this cell population exhibits multiple properties of ovarian cancer stem cells, including chemoresistance and the property to differentiate into multiple cell types [231].